Bone Marrow TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationGraft vs Host DiseaseHematologic NeoplasmsTransplantation ConditioningHematopoietic Stem Cell MobilizationTransplantation ChimeraGranulocyte Colony-Stimulating FactorGraft SurvivalBone MarrowTransplantation, AutologousTissue DonorsBusulfanBone Marrow CellsAntigens, CD34LeukapheresisWhole-Body IrradiationGraft vs Leukemia EffectVidarabineLeukemiaTreatment OutcomeRecurrenceImmunosuppressive AgentsHistocompatibilityHistocompatibility TestingHematopoietic Stem CellsAnemia, AplasticCyclophosphamideSurvival AnalysisBone and BonesRetrospective StudiesMyeloablative AgonistsT-LymphocytesCombined Modality TherapyPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow PurgingHLA AntigensTransplantation, IsogeneicChronic DiseaseLiver TransplantationHematopoiesisTransplantation ImmunologyStem Cell TransplantationBlood Component RemovalMelphalanDisease-Free SurvivalStem CellsBone Marrow DiseasesRemission InductionLymphoma, Non-HodgkinLeukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsMultiple MyelomaBlood CellsCyclosporineLymphocyte TransfusionMice, Inbred C57BLLymphocyte DepletionLeukocyte TransfusionKidney TransplantationRadiation ChimeraEtoposideCord Blood Stem Cell TransplantationImmunosuppressionAcute DiseaseLeukemia, MyeloidBlood Cell CountColony-Forming Units AssayGraft RejectionFlow CytometryMyelodysplastic SyndromesLeukocyte CountHematologic DiseasesCytarabineHepatic Veno-Occlusive DiseaseGraft vs Tumor EffectSurvival RateGraft vs Host ReactionBone Marrow ExaminationCells, CulturedImmunophenotypingCytomegalovirus InfectionsLeukocytes, MononuclearNuclear FamilyRecombinant ProteinsInfectionLymphomaCarmustineCell SeparationChimeraFollow-Up StudiesBone RemodelingHodgkin DiseaseBone Marrow NeoplasmsLymphocytesHeart Transplantation